Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Journal Volume
17
Journal Issue
12
Date Issued
2022-12
Author(s)
Lin, Emily Pei-Ying
Hsu, Chih-Yuan
Chiou, Jeng-Fong
Berry, Lynne
Horn, Leora
Bunn, Paul
Adjei, Alex A
Shyr, Yu
Abstract
Survival benefit of immune checkpoint inhibitor (ICI) therapy in lung cancer is not fully understood.
Subjects
Cox HR; Cox-TEL; Immune checkpoint inhibitor; Long-term survival; PD-L1
SDGs
Type
journal article